Close

Cleveland Biolabs (CBLI) Says Entolimod Shown to Suppress Metastasis and Induce Immunity by Stimulating NK-Dendritic-CD8+ T cell Axis Feb 9, 2016 07:51AM
Entolimod Shown to Suppress Metastasis and Induce Immunity by Stimulating NK-Dendritic-CD8+ T cell Axis in Studies by Cleveland BioLabs and Roswell Park Cancer Institute Feb 9, 2016 07:30AM
Cleveland Biolabs (CBLI) Says Entolimod Shown to Suppress Liver Metastases in Model of Ocular Melanoma Dec 14, 2015 07:40AM
Entolimod Shown to Suppress Liver Metastases in Model of Ocular Melanoma in Collaborative Study by Cleveland BioLabs, Emory University and Roswell Park Cancer Institute Dec 14, 2015 07:30AM
Cleveland BioLabs and Roswell Park Cancer Institute Announce Award of Department of Defense Breast Cancer Research Program Breakthrough Grant for Entolimod Apr 27, 2015 07:30AM


Apr 16, 2014 09:24AM Pre-Open Stock Movers 4/16: (ZLCS) (SODA) (YHOO) Higher; (ASML) (CSX) (TWTR) Lower (more...)